Altos, headed by Hal Barron, MD CEO and Rick Klausner, MD CSO and founder launched in January 2022 with three billion dollars in funding. The new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming. Altos’ mission is to restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life. Altos has a remarkable line of scientists and leaders.
×
Altos � Cellular reprogramming technology
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD